Dr. Antoni Chan synovialjoints
5 years 11 months ago
About half (51%) of patients from the FORWARD registry in the US had at least one telehealth appointment during COVID-19 pandemic and most were satisfied with the appointment @RheumNow #ACR20 Abstr#1962 https://t.co/z38ilD1n8Q
Meral K. El Ramahi, MD MeralElRamahiMD
5 years 11 months ago
Summary of #ACR20 part A:
- HCQ is not a problem in rheumatic dz pts in terms of causing QTc prolongation
- Anti-phospholipid ab are found in a majority of hospitalized COVID19 pts — the most prevalent of which were anti-PST abs that are not in the of criteria for APS
@rheumnow
Dr. John Cush RheumNow
5 years 11 months ago
RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by @bmsnews, @HorizonNews, @SanofiGenzyme, @Novartis. All content chosen by @RheumNow & its Faculty.
The final day (day 4) of the ACR 2020 meeting saw a flurry of late-breaking abstracts and other novel studies that excited our faculty. Below are some of their choices for #ACRbest.
Addressing Fatigue in Rheumatoid Arthritis: Dr Eric Dein
Dr. Eric Dein reviews abstract #1737 at the 2020 ACR Annual Meeting.
Dr. Ken Saag - RECIPE Study: MMF with Pegloticase
Dr. Jack Cush interviews Dr. Ken Saag about the benefits of adding mycophenolate to your pegloticase regimen in refractory gout patients.
Flu and Tofacitinib: Dr. Kathryn Dao
Dr. Kathryn Dao reviews abstract L04 at the 2020 ACR annual meeting.
Outcomes of COVID in Rheumatic Disease Patients: Dr. Eric Dein
Dr. Eric Dein reviews abstract L01 presented at the 2020 ACR annual meeting.
Robert B Chao, MD doctorRBC
5 years 11 months ago
Hey Google, does this patient have sacroilitis?
Artificial intelligence model validated for detection of radiographic sacroilitis.
@RheumNow #ACR20 Abs#2018 https://t.co/TDhGKC8ss4
Dr. Antoni Chan synovialjoints
5 years 11 months ago
What was the effect of COVID-19 in axSpA patients? From @rheum_cat In the early phase of COVID-19 there was a higher levels of stress and anxiety leading to higher BASDAI scores @RheumNow #ACR20 Abstr#1884
Eric Dein ejdein1
5 years 11 months ago
Abst#2001: Heme changes on MTX? CIRT trial (non-rheumatic pts): Low-dose MTX (15-20mg/w): 2 line cytopenia uncommon (4%), pancytopenia rare (0.5%), Hb decrease 0.4 g/dL but WBC, plt unchanged. Reassuring large pop study shows tolerance of MTX #ACR20 @Rheumnow
Eric Dein ejdein1
5 years 11 months ago
Abst#2000. PRIME team Medicare database study pts with new RA started on MTX higher VTE risk than HCQ (HR 2.3). Unable to assess disease activity because claims database, but would imagine MTX grp more severe, driving increased VTE risk @RheumNow #ACR20 https://t.co/Z14xFTVXTp
Dr. Antoni Chan synovialjoints
5 years 11 months ago
The majority of patients with axSpA were able to use an axSpA smartphone app. recording BASDAI, BASFI 2 weekly. Current disease activity influence adherence to reporting @RheumNow #ACR20 Abstr#1890
Dr. John Cush RheumNow
5 years 11 months ago
Test your ACR IQ and see where you place on our leaderboard. #ACR20
https://t.co/DKSq8gKTDb https://t.co/lGUEbVbg1g
Pregnancy and ILD: Dr. David Liew
Dr. David Liew reviews abstract #1446 presented at the 2020 ACR annual meeting.
